Overview Study to Determine the Pharmacokinetics of Product 0405 Status: Withdrawn Trial end date: 2013-05-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the Pharmacokinetics of Product 0405 in the Treatment of Atopic Dermatitis in Adolescent Subjects. Phase: Phase 3 Details Lead Sponsor: Fougera Pharmaceuticals Inc.